- Home
- VNET vs ARWR Comparison
VNET vs ARWR Comparison
Compare VNET & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNET
- ARWR
- Stock Information
- Founded
- VNET 1999
- ARWR 2003
- Country
- VNET China
- ARWR United States
- Employees
- VNET N/A
- ARWR N/A
- Industry
- VNET Computer Software: Programming Data Processing
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- VNET Technology
- ARWR Health Care
- Exchange
- VNET Nasdaq
- ARWR Nasdaq
- Market Cap
- VNET 2.6B
- ARWR 2.5B
- IPO Year
- VNET 2011
- ARWR 1993
- Fundamental
- Price
- VNET $9.60
- ARWR $36.14
- Analyst Decision
- VNET Strong Buy
- ARWR Strong Buy
- Analyst Count
- VNET 4
- ARWR 8
- Target Price
- VNET $11.20
- ARWR $47.75
- AVG Volume (30 Days)
- VNET 8.1M
- ARWR 2.3M
- Earning Date
- VNET 11-19-2025
- ARWR 11-25-2025
- Dividend Yield
- VNET N/A
- ARWR N/A
- EPS Growth
- VNET N/A
- ARWR N/A
- EPS
- VNET N/A
- ARWR N/A
- Revenue
- VNET $1,262,962,115.00
- ARWR $572,976,000.00
- Revenue This Year
- VNET $18.94
- ARWR $21,421.26
- Revenue Next Year
- VNET $19.44
- ARWR N/A
- P/E Ratio
- VNET $441.41
- ARWR N/A
- Revenue Growth
- VNET 17.85
- ARWR 2816.20
- 52 Week Low
- VNET $3.17
- ARWR $9.57
- 52 Week High
- VNET $16.13
- ARWR $39.42
- Technical
- Relative Strength Index (RSI)
- VNET 49.06
- ARWR 70.36
- Support Level
- VNET $9.63
- ARWR $31.46
- Resistance Level
- VNET $11.80
- ARWR $39.38
- Average True Range (ATR)
- VNET 0.83
- ARWR 1.42
- MACD
- VNET -0.15
- ARWR -0.04
- Stochastic Oscillator
- VNET 16.95
- ARWR 62.01
About VNET VNET Group Inc.
VNET started as AsiaCloud in 1999 and moved to the data center business with its first self-developed data center opening in 2010. The firm listed (as 21Vianet) on the Nasdaq in April 2011, subsequently changing its name to VNET Group in 2021. It originally focused on providing data center services such as colocation and cloud services to retail clients in China, but added hyperscale customers in 2019 and now counts large Chinese hyperscalers such as Alibaba Cloud, Tencent Cloud, and Huawei Cloud as customers. At the end of June 2025, it had 51,960 retail cabinets with the majority in Beijing, Shanghai, and the Greater Bay area. It also had 674 MW of wholesale capacity in service with a further 326 MW under construction and a further 792 MW held for future development.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.